A Problem-based Health System Framework for Promoting Diabetes Remission: Systematic Outcomes of the Roi-Et Health Network
DOI:
https://doi.org/10.64960/srimedj.v41i2.270639Keywords:
diabetes remission, problem-based learning, health network, self-care behaviorAbstract
Background and objectives: Diabetes mellitus is a chronic condition characterized by the body's inability to effectively regulate blood glucose levels, which, if left unmanaged, can lead to severe systemic complications. This study aimed to investigate operational problems, develop and implement a problem-based model, and evaluate the effectiveness of an intervention program designed to promote Diabetes Remission.
Methods: This study employed a Research and Development (R&D) design. The sample consisted of 220 multidisciplinary team members and health volunteers, along with 4,031 diabetic patients participating in the project. Data were collected using questionnaires, record forms, and semi-structured interview guides. Statistical analysis included frequency, percentage, mean, standard deviation, and paired t-test (at a 95% confidence interval), supplemented by content analysis for qualitative data.
Results: 1) The situational analysis of diabetes care in Roi-Et Province identified challenges across four dimensions: patient and social context, service providers, service management systems, and resources/medical supplies. 2) The developed "Problem-Based Diabetes Remission Model" comprised key activities: identifying eligible candidates, collaborative goal setting, skill-building schools, technology-assisted monitoring, clinical multidisciplinary teams for medication adjustment, motivation and network building, and intensive follow-up. 3) Post-intervention results showed that patients’ self-care behavior scores were significantly higher than pre-intervention levels across all domains (p<0.001). Among the participants who completed the 3-month evaluation (n = 2,261), 1,004 patients (24.91% of total participants) achieved Diabetes Remission, defined as maintaining an HbA1c < 6.5% without medication for at least 3 months. Furthermore, 30.22% (1,218 patients) achieved Medication Reduction. Regarding clinical stability and safety, 30.79% maintained stable medication levels, while only 0.45% required a dosage increase, and the loss-to-follow-up rate was remarkably low at 0.27%.
Conclusion: Promoting diabetes remission through intensive skill training and close monitoring significantly improves self-care behaviors. This approach effectively enables patients to achieve disease remission and reduce reliance on pharmacological treatments.
References
Aekplakorn W, Patanavanich R, Chariyalertsak S, Bumrerraj S, Assanangkornchai S, Taneepanichskul S, et al. Diabetes trends and determinants among Thai adults from 2004 to 2020. Sci Rep 2025;15(1):31620. doi:10.1038/s41598-025-17619-5.
Wongpairin A, Lim A, Khurram H. The Prevalence and Prediction of Uncontrolled Type 2 Diabetes Mellitus in the Lower South of Thailand. J Health Res 2025;39(3):274-81. doi:10.56808/2586-940X.1144.
Lueaphon C, Hanon N. Development of a care system for patients with type 2 diabetes mellitus in Sri Somdet District, Roi Et Province. Journal of Research and Health Innovation Development 2024;5(1):212-25.
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2022;65(12):1925-66. doi:10.1007/s00125-022-05787-2.
World Health Organization. Diabetes [Internet]. Geneva: World Health Organization; 2024 [cited Jan 27, 2026]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
International Diabetes Federation. IDF Diabetes Atlas [Internet]. 10th ed. Brussels: International Diabetes Federation; 2021 [cited Jan 27, 2026]. Available from: https://www.diabetesatlas.org
Somanawat J, Saramunee K, Chanasopon S. Process, quality and challenges of diabetes care in primary care: a study of district health network in Thailand. Prim Health Care Res Dev 2020;21:e46. doi:doi:10.1017/S1463423620000468.
Alhumaidi B. Developing a culturally sensitive structured diabetes education programme for people living with type 2 diabetes in Saudi Arabia [PhD thesis]. Glasgow: University of Glasgow; 2022. [cited Jan 27, 2026]. Available from: https://theses.gla.ac.uk/83169/3/2022AlhumaidiPhD.pdf
Taheri S, Zaghloul H, Chagoury O, Elhadad S, Ahmed SH, El Khatib N, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 2020;8(6):477-89. doi:10.1016/S2213-8587(20)30117-0.
Lean MEJ, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol 2019;7(5):344-55. doi:10.1016/S2213-8587(19)30068-3
Kelly J, Karlsen M, Steinke G. Type 2 Diabetes Remission and Lifestyle Medicine: A Position Statement From the American College of Lifestyle Medicine. Am J Lifestyle Med 2020;14(4):406-19. doi:10.1177/1559827620930962.
Zhang Y, Yang Y, Huang Q, Zhang Q, Li M, Wu Y. The effectiveness of lifestyle interventions for diabetes remission on patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Worldviews Evid Based Nurs 2023;20(1):64-77. doi:10.1111/wvn.12608.
American Diabetes Association. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes—2020. Diabetes Care 2020;43(Suppl 1):S48-S65. doi:10.2337/dc21-S005.
Holman N, Khunti K, Wild SH, Sattar N, Knighton P, Young B, et al. Care processes in people in remission from type 2 diabetes: A cohort study using the National Diabetes Audit. Diabet Med 2023;40(3):e15016. doi:10.1111/dme.15016.
Taheri S, Zaghloul H, Chagoury O, Elhadad S, Ahmed SH, El Khatib N, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2020;8(6):477-89. doi:10.1016/S2213-8587(20)30117-0.
Goldenberg JZ, Day A, Brinkworth GD, Sato J, Yamada S, Jönsson T, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 2021;372:m4743. doi:10.1136/bmj.m4743.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Srinagarind Medical Journal

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
